Tissue Regenix (UK) Probability of Future Stock Price Finishing Over 58.50
TRX Stock | 58.50 1.50 2.50% |
Tissue |
Tissue Regenix Target Price Odds to finish over 58.50
The tendency of Tissue Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
58.50 | 90 days | 58.50 | about 35.26 |
Based on a normal probability distribution, the odds of Tissue Regenix to move above the current price in 90 days from now is about 35.26 (This Tissue Regenix Group probability density function shows the probability of Tissue Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Tissue Regenix Group has a beta of -0.28. This usually implies as returns on the benchmark increase, returns on holding Tissue Regenix are expected to decrease at a much lower rate. During a bear market, however, Tissue Regenix Group is likely to outperform the market. Additionally Tissue Regenix Group has an alpha of 0.1262, implying that it can generate a 0.13 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Tissue Regenix Price Density |
Price |
Predictive Modules for Tissue Regenix
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Tissue Regenix Group. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Tissue Regenix Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Tissue Regenix is not an exception. The market had few large corrections towards the Tissue Regenix's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Tissue Regenix Group, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Tissue Regenix within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.13 | |
β | Beta against Dow Jones | -0.28 | |
σ | Overall volatility | 2.75 | |
Ir | Information ratio | 0.07 |
Tissue Regenix Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Tissue Regenix for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Tissue Regenix Group can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.The company reported the revenue of 29.49 M. Net Loss for the year was (1.67 M) with profit before overhead, payroll, taxes, and interest of 11.26 M. | |
About 52.0% of the company outstanding shares are owned by corporate insiders | |
Latest headline from news.google.com: Tissue Regenix Sees Shift in IP Group Voting Rights - TipRanks |
Tissue Regenix Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Tissue Stock often depends not only on the future outlook of the current and potential Tissue Regenix's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Tissue Regenix's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 70.4 M | |
Cash And Short Term Investments | 4.7 M |
Tissue Regenix Technical Analysis
Tissue Regenix's future price can be derived by breaking down and analyzing its technical indicators over time. Tissue Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Tissue Regenix Group. In general, you should focus on analyzing Tissue Stock price patterns and their correlations with different microeconomic environments and drivers.
Tissue Regenix Predictive Forecast Models
Tissue Regenix's time-series forecasting models is one of many Tissue Regenix's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Tissue Regenix's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Tissue Regenix Group
Checking the ongoing alerts about Tissue Regenix for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Tissue Regenix Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
The company reported the revenue of 29.49 M. Net Loss for the year was (1.67 M) with profit before overhead, payroll, taxes, and interest of 11.26 M. | |
About 52.0% of the company outstanding shares are owned by corporate insiders | |
Latest headline from news.google.com: Tissue Regenix Sees Shift in IP Group Voting Rights - TipRanks |
Other Information on Investing in Tissue Stock
Tissue Regenix financial ratios help investors to determine whether Tissue Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tissue with respect to the benefits of owning Tissue Regenix security.